These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21282815)

  • 1. Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension.
    Lee WT; Kirkham N; Johnson MK; Lordan JL; Fisher AJ; Peacock AJ
    Eur Respir J; 2011 Feb; 37(2):472-4. PubMed ID: 21282815
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver toxicity of sitaxentan in pulmonary arterial hypertension.
    Galiè N; Hoeper MM; Gibbs JS; Simonneau G
    Eur Respir J; 2011 Feb; 37(2):475-6. PubMed ID: 21282816
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver toxicity of sitaxentan in pulmonary arterial hypertension.
    Galiè N; Hoeper MM; Simon J; Gibbs R; Simonneau G;
    Eur Heart J; 2011 Feb; 32(4):386-7. PubMed ID: 21416695
    [No Abstract]   [Full Text] [Related]  

  • 4. Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan.
    Don GW; Joseph F; Celermajer DS; Corte TJ
    Intern Med J; 2012 Dec; 42(12):1351-4. PubMed ID: 23253000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension.
    Lavelle A; Sugrue R; Lawler G; Mulligan N; Kelleher B; Murphy DM; Gaine SP
    Eur Respir J; 2009 Sep; 34(3):770-1. PubMed ID: 19720812
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension].
    Montani D; Humbert M
    Rev Mal Respir; 2010 Feb; 27(2):103-5. PubMed ID: 20206056
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful up-front combination therapy in a patient with idiopathic pulmonary hypertension and patent foramen ovale: an alternative to epoprostenol therapy?
    Pitsiou GG; Chavouzis N; Nakou C; Boutou AK; Argyropoulou P; Stanopoulos I
    J Heart Lung Transplant; 2009 Jun; 28(6):651-3. PubMed ID: 19481029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary arterial hypertension occurrence after liver transplant in systemic sclerosis: a report of 2 cases sustainably treated by sildenafil.
    Koumakis E; Wipff J; Kahan A; Allanore Y
    Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S53-4. PubMed ID: 20576215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary hypertension treatment: future prospects].
    Baloira A
    Arch Bronconeumol; 2007 Mar; 43(3):131-5. PubMed ID: 17386188
    [No Abstract]   [Full Text] [Related]  

  • 10. An evidence-based approach to the management of pulmonary arterial hypertension.
    Coyne TC
    Curr Opin Cardiol; 2006 Sep; 21(5):526; author reply 526-7. PubMed ID: 16900019
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical characteristics and outcome of 13 dogs with pulmonary arterial hypertension (PH) treated with sildenafil.
    Moreno HJ
    J Vet Intern Med; 2007; 21(6):1165. PubMed ID: 18196719
    [No Abstract]   [Full Text] [Related]  

  • 12. Sildenafil and steroid therapy effectively improved POEMS syndrome-associated pulmonary arterial hypertension.
    Shimomura Y; Hara M; Mizote I; Nakaoka Y; Tanaka H; Asano Y; Sakata Y; Komuro I
    Int J Hematol; 2010 Dec; 92(5):774-6. PubMed ID: 21132469
    [No Abstract]   [Full Text] [Related]  

  • 13. Exacerbation of AIH in a patient with an AIH/systemic sclerosis overlap syndrome and pulmonary arterial hypertension treated with the endothelin-1 receptor antagonist sitaxentan.
    Klein R; Hintz E; Staehler G
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22802555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis.
    Lefebvre MC; Hunsche E
    Appl Health Econ Health Policy; 2010; 8(1):69-71; author reply 71-3. PubMed ID: 20238466
    [No Abstract]   [Full Text] [Related]  

  • 15. [Specific drugs for the treatment of pulmonary arterial hypertension - current status].
    Stähler G
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S183-6. PubMed ID: 18814092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil in idiopathic pulmonary fibrosis.
    Maher TM
    N Engl J Med; 2010 Nov; 363(22):2169; author reply 2170-1. PubMed ID: 21105804
    [No Abstract]   [Full Text] [Related]  

  • 18. Inoperable chronic thromboembolic pulmonary hypertension: treatable with medical therapy.
    Hill NS; Preston IR; Roberts KE
    Chest; 2008 Aug; 134(2):221-223. PubMed ID: 18682450
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of primary ciliary dyskinesia with pulmonary arterial hypertension responding to oral sildenafil.
    Datta G; Dastidar DG; Kundu S; Datta B; Dastidar NG; Bannerjee A
    J Assoc Physicians India; 2011 Nov; 59():738-40. PubMed ID: 22616346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil: a definitive NO in COPD.
    Vonk-Noordegraaf A; Boerrigter BG
    Eur Respir J; 2013 Oct; 42(4):893-4. PubMed ID: 24081756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.